Lebectin and lebecetin, two C-type lectins from snake venom, inhibit α5β1 and αv-containing integrins

Matrix Biology

Volumn 26, Issue 4, 2007, Pages 306-313

  Sarray, Sameh ^a,b   Delamarre, Estelle ^c   Marvaldi, Jacques ^c   Ayeb, Mohamed El ^a   Marrakchi, Naziha ^a,d   Luis, José ^c  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^c AIX MARSEILLE UNIVERSITY   (France)

^d UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Cell migration; Cell proliferation; Haptotaxis; Integrin; Invasion; Snake venom; Tumour cell adhesion

Indexed keywords

CD51 ANTIGEN; LEBECETIN; LEBECTIN; LECTIN; SNAKE VENOM; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5;

ANALYTIC METHOD; ARTICLE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; TUMOR CELL;

MACROVIPERA LEBETINA;

EID: 34247548781     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2007.01.001     Document Type: Article

References (46)

1. Andrews R.K., and Berndt M.C. Snake venom modulators of platelet adhesion receptors and their ligands. Toxicon 38 (2000) 775-791
2. Aplin A., Howe A., Alahari S., and Juliano R. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol. Rev. 50 (1998) 197-263
3. Bergmeier W., Bouvard D., Eble J.A., Mokhtari-Nejad R., Schulte V., Zirngibl H., Brakebusch C., Fassler R., and Nieswandt B. Rhodocytin (aggretin) activates platelets lacking α2β1 integrin, glycoprotein VI, and the ligand-binding domain of glycoprotein Iba. J. Biol. Chem. 276 (2001) 25121-25126
4. Berthet V., Rigot V., Nejjari M., Marvaldi J., and Luis J. The endoproteolytic processing of αvβ5 integrin is involved in cytoskeleton remodelling and cell migration. FEBS Lett. 557 (2004) 159-163
5. Braud S., Bon C., and Wisner A. Snake venom proteins acting on hemostasis. Biochimie 82 (2000) 851-859
6. Cardarelli P.M., Yamagata S., Taguchi I., Gorcsan F., Chiang S.L., and Lobl T. The collagen receptor alpha 2 beta 1, from MG-63 and HT1080 cells, interacts with a cyclic RGD peptide. J. Biol. Chem. 267 (1992) 23159-23164
7. Chung C.H., Peng H.C., and Huang T.F. Aggretin, a C-type lectin protein, induces platelet aggregation via integrin α2β1 and GPIb in a phosphatidylinositol 3-kinase independent pathway. Biochem. Biophys. Res. Commun. 285 (2001) 689-695
8. Clezardin P. Recent insights into the role of integrins in cancer metastasis. Cell. Mol. Life Sci. 54 (1998) 541-548
9. Cruet-Hennequart S., Maubant S., Luis J., Gauduchon P., Staedel C., and Dedhar S. αv integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells. Oncogene 22 (2003) 1688-1702
10. de Carvalho D.D., Schmitmeier S., Novello J.C., and Markland F.S. Effect of BJcuL (a lectin from the venom of the snake Bothrops jararacussu) on adhesion and growth of tumor and endothelial cells. Toxicon 39 (2001) 1471-1476
11. Du X.Y., Navdaev A., Clemetson J.M., Magnenat E., Wells T.N., and Clemetson K.J. Bilinexin, a snake C-type lectin from Agkistrodon bilineatus venom agglutinates platelets via GPIb and α2β1. Thromb. Haemost. 86 (2001) 1277-1283
12. Du X.-Y., Magnenat E., Wells T.N., and Clemetson K.J. Alboluxin, a snake C-type lectin from Trimeresurus albolabris venom is a potent platelet agonist acting via GPIb and GPVI. Thromb. Haemost. 87 (2002) 692-698
13. Eble J.A., and Tuckwell D.S. The alpha2beta1 integrin inhibitor rhodocetin binds to the A-domain of the integrin alpha2 subunit proximal to the collagen-binding site. Biochem. J. 376 (2003) 77-85
14. Eble J.A., Beermann B., Hinz H.J., and Schmidt-Hederich A. α2β1 integrin is not recognized by rhodocytin but is the specific, high affinity target of rhodocetin, an RGD-independent disintegrin and potent inhibitor of cell adhesion to collagen. J. Biol. Chem. 276 (2001) 12274-12284
15. Eble J.A., Niland S., Dennes A., Schmidt-Hederich A., Bruckner P., and Brunner G. Rhodocetin antagonizes stromal tumor invasion in vitro and other alpha2beta1 integrin-mediated cell functions. Matrix Biol. 21 (2002) 547-558
16. Emsley J., Knight C.G., Farndale R.W., Barnes M.J., and Liddington R.C. Structural basis of collagen recognition by integrin α2β1. Cell 101 (2000) 47-56
17. Fukuda K., Doggett T.A., Bankston L.A., Cruz M.A., Diacovo T.G., and Liddington R.C. Structural basis of von Willebrand factor activation by the snake toxin botrocetin. Structure (Camb) 10 (2002) 943-950
18. Geiger B., Bershadsky A., Pankov R., and Yamada K.M. Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat. Rev. Mol. Cell Biol. 2 (2001) 793-805
19. Giancotti F.G., and Ruoslahti E. Integrin signaling. Science 285 (1999) 1028-1032
20. Guo W., and Giancotti F.G. Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 5 (2004) 816-826
21. Horii K., Okuda D., Morita T., and Mizuno H. Crystal structure of EMS16 in complex with the integrin alpha2-I domain. J. Mol. Biol. 341 (2004) 519-527
22. Humphries M.J. Integrin structure. Biochem. Soc. Trans. 28 (2000) 311-339
23. Hynes R.O. Cell adhesion: old and new questions. Trends Cell Biol. 9 (1999) M33-M37
24. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
25. Jones P.A., Laug W.E., and Benedict W.F. Fibrinolytic activity in a human fibrosarcoma cell line and evidence for the induction of plasminogen activator secretion during tumor formation. Cell 6 (1975) 245-252
26. Kadi A., Pichard V., Lehmann M., Briand C., Braguer D., Marvaldi J., Rognoni J.-B., and Luis J. Effect of microtubule disruption on cell adhesion and spreading. Biochem. Biophys. Res. Commun. 246 (1998) 690-695
27. Kanaji S., Kanaji T., Furihata K., Kato K., Ware J.L., and Kunicki T.J. Convulxin binds to native, human glycoprotein Ib alpha. J. Biol. Chem. 278 (2003) 39452-39460
28. Lehmann M., Rabenandrasana C., Tamura R., Lissitzky J.-C., Quaranta V., Pichon J., and Marvaldi J. A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins αvβ3, αvβ5, and αvβ6. Cancer Res. 54 (1994) 2102-2107
29. Lu Q., Navdaev A., Clemetson J.M., and Clemetson K.J. Snake venom C-type lectins interacting with platelet receptors. Structure-function relationships and effects on haemostasis. Toxicon 45 (2005) 1089-1098
30. Maita N., Nishio K., Nishimoto E., Matsui T., Shikamoto Y., Morita T., Sadler J.E., and Mizuno H. Crystal structure of von Willebrand factor A1 domain complexed with snake venom, bitiscetin: insight into glycoprotein Ibalpha binding mechanism induced by snake venom proteins. J. Biol. Chem. 278 (2003) 37777-37781
31. Marcinkiewicz C., Lobb R.R., Marcinkiewicz M.M., Daniel J.L., Smith J.B., Dangelmaier C., Weinreb P.H., Beacham D.A., and Niewiarowski S. Isolation and characterization of EMS16, a C-lectin type protein from Echis multisquamatus venom, a potent and selective inhibitor of the α2β1 integrin. Biochemistry 39 (2000) 9859-9867
32. McLane M.A., Sanchez E.E., Wong A., Paquette-Straub C., and Perez J.C. Disintegrins. Curr. Drug Targets Cardiovasc. Haematol. Disord. 4 (2004) 327-355
33. Naito M., Nomura H., and Iguchi A. Migration of cultured vascular smooth muscle cells into non-crosslinked fibrin gels. Thromb. Res. 84 (1996) 129-136
34. Navdaev A., Clemetson J.M., Polgar J., Kehrel B.E., Glauner M., Magnenat E., Wells T.N., and Clemetson K.J. Aggretin, a heterodimeric C-type lectin from Calloselasma rhodostoma (malayan pit viper), stimulates platelets by binding to α2β1 integrin and glycoprotein Ib, activating Syk and phospholipase Cγ2 but does not involve the glycoprotein VI/Fc receptor γ chain collagen receptor. J. Biol. Chem. 276 (2001) 20882-20889
35. Nejjari M., Berthet V., Rigot V., Laforest S., Jacquier M.F., Seidah N.G., Rémy L., Bruyneel E., Scoazec J.Y., Marvaldi J., and Luis J. Inhibition of proprotein convertases enhances cell migration and metastases development of human colon carcinoma cells in a rat model. Am. J. Pathol. 164 (2004) 1925-1933
36. Ogawa T., Chijiwa T., Oda-Ueda N., and Ohno M. Molecular diversity and accelerated evolution of C-type lectin-like proteins from snake venom. Toxicon 45 (2005) 1-14
37. Parise L.V., Lee J., and Juliano R.L. New aspects of integrin signaling in cancer. Semin. Cancer Biol. 10 (2000) 407-414
38. Rigot V., Lehmann M., André F., Daemi N., Marvaldi J., and Luis J. Integrin ligation and PKC activation are required for migration of colon carcinoma cells. J. Cell Sci. 111 (1998) 3119-3127
39. Sarray S., Srairi N., Hatmi M., Luis J., Louzir H., Regaya I., Slema H., Marvaldi J., El Ayeb M., and Marrakchi N. Lebecetin, a potent antiplatelet C-type lectin from Macrovipera lebetina venom. Biochim. Biophys. Acta 1651 (2003) 30-40
40. Sarray S., Berthet V., Calvete J.J., Secchi J., Marvaldi J., El-Ayeb M., Marrakchi N., and Luis J. Lebectin, a novel C-type lectin from Macrovipera lebetina venom, inhibits integrin-mediated adhesion, migration and invasion of human tumour cells. Lab. Invest. 84 (2004) 573-581
41. Small J.V., Kaverina I., Krylyshkina O., and Rottner K. Cytoskeleton cross-talk during cell motility. FEBS Lett. 452 (1999) 96-99
42. Suzuki-Inoue K., Ozaki Y., Kainoh M., Shin Y., Wu Y., Yatomi Y., Ohmori T., Tanaka T., Satoh K., and Morita T. Rhodocytin induces platelet aggregation by interacting with glycoprotein Ia/IIa (GPIa/IIa, Integrin α2β1). Involvement of GPIa/IIa-associated src and protein tyrosine phosphorylation. J. Biol. Chem. 276 (2001) 1643-1652
43. Suzuki-Inoue K., Fuller G.L., Garcia A., Eble J.A., Pohlmann S., Inoue O., Gartner T.K., Hughan S.C., Pearce A.C., Laing G.D., Theakston R.D., Schweighoffer E., Zitzmann N., Morita T., Tybulewicz V.L., Ozaki Y., and Watson S.P. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 107 (2006) 542-549
44. Takagi J., Erickson H.P., and Springer T.A. C-terminal opening mimics 'inside-out' activation of integrin alpha5beta1. Nat. Struct. Biol. 8 (2001) 412-416
45. Takagi J., Petre B.M., Walz T., and Springer T.A. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 110 (2002) 599-511
46. Yatogho T., Izumi M., Kashiwagi H., and Hayashi M. Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct. Funct. 13 (1988) 281-292